Interestingly, DDIAS expression is highly correlated with STAT3 phosphorylation in human lung cancer cell lines and tissues, regardless of PTPRM expression8, and is considered a potential biomarker and therapeutic target in malignant lung cancer cells with aberrant STAT3 activation. This evidence concerns the gene PTPRM and lung cancer.